===== phenotype 5=================================================================
proportion of pts: 0.119397064657
lambda: 16186.2895539
----------------------------------------
Ischemic heart disease	0.140
Other forms of heart disease	0.122
Hypertensive disease	0.105
Disorders of lipoid metabolism	0.104
Nephritis, nephrotic syndrome, and nephrosis	0.092
Range name na	0.084
Symptoms involving respiratory system and other chest symptoms	0.083
Anemias	0.079
Other diseases of respiratory system	0.072
Disorders of fluid, electrolyte, and acid-base balance	0.065
Disorders of the eye and adnexa	0.055
----------------------------------------
Diuretics	0.077
Adrenergic beta-1 Receptor Antagonists	0.074
Sympatholytics	0.072
Anti-Arrhythmia Agents	0.072
Platelet Aggregation Inhibitors	0.069
Anticholesteremic Agents	0.069
Fibrinolytic Agents	0.067
Vasodilator Agents	0.065
Anti-Inflammatory Agents, Non-Steroidal	0.065
Cyclooxygenase Inhibitors	0.065
Antihypertensive Agents	0.063
Antipyretics	0.063
Sodium Potassium Chloride Symporter Inhibitors	0.063
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.061
Hypolipidemic Agents	0.055
===== phenotype 47=================================================================
proportion of pts: 0.138437128124
lambda: 15273.2333299
----------------------------------------
Disorders of lipoid metabolism	0.140
Hypertensive disease	0.140
Acute respiratory infections	0.111
Arthropathies and related disorders	0.107
Diabetes	0.091
Symptoms involving respiratory system and other chest symptoms	0.075
Other diseases of the upper respiratory tract	0.070
Rheumatism, excluding the back	0.069
Range name na	0.067
Disorders of the eye and adnexa	0.066
Diseases of the ear and mastoid process	0.065
----------------------------------------
Anti-Inflammatory Agents, Non-Steroidal	0.079
Cyclooxygenase Inhibitors	0.079
Antihypertensive Agents	0.075
Antipyretics	0.074
Platelet Aggregation Inhibitors	0.073
Anticholesteremic Agents	0.073
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.073
Fibrinolytic Agents	0.072
Diuretics	0.064
Sodium Chloride Symporter Inhibitors	0.061
Anti-Inflammatory Agents	0.056
Vasodilator Agents	0.056
Hypolipidemic Agents	0.056
Hypoglycemic Agents	0.055
Anti-Allergic Agents	0.054
===== phenotype 2=================================================================
proportion of pts: 0.122173740579
lambda: 15230.1836366
----------------------------------------
Hypertensive disease	0.141
Disorders of lipoid metabolism	0.120
Other forms of heart disease	0.114
Symptoms involving respiratory system and other chest symptoms	0.087
Range name na	0.085
Symptoms involving cardiovascular system	0.077
Symptoms involving skin and other integumentary tissue	0.076
Nonspecific findings on examination of blood	0.067
Ischemic heart disease	0.066
General symptoms	0.059
Rheumatism, excluding the back	0.055
Arthropathies and related disorders	0.054
----------------------------------------
Vasodilator Agents	0.071
Anti-Arrhythmia Agents	0.069
Diuretics	0.068
Antihypertensive Agents	0.067
Anti-Inflammatory Agents, Non-Steroidal	0.065
Platelet Aggregation Inhibitors	0.064
Fibrinolytic Agents	0.064
Cyclooxygenase Inhibitors	0.063
Calcium Channel Blockers	0.062
Antipyretics	0.062
Adrenergic beta-1 Receptor Antagonists	0.059
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.059
Sympatholytics	0.058
Sodium Chloride Symporter Inhibitors	0.058
Angiotensin-Converting Enzyme Inhibitors	0.056
Anticholesteremic Agents	0.055
===== phenotype 44=================================================================
proportion of pts: 0.11106703689
lambda: 14807.7481093
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.096
Hypertensive disease	0.093
Mycoses	0.088
Disorders of lipoid metabolism	0.085
Disorders of the eye and adnexa	0.075
Arthropathies and related disorders	0.073
Ischemic heart disease	0.070
Diabetes	0.065
Range name na	0.063
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.063
Other inflammatory conditions of skin and subcutaneous tissue	0.062
Diseases of esophagus, stomach, and duodenum	0.058
Rheumatism, excluding the back	0.057
Other diseases of intestines and peritoneum	0.052
----------------------------------------
Cardiotonic Agents	0.072
Angiotensin-Converting Enzyme Inhibitors	0.071
Anticholesteremic Agents	0.070
Proton Pump Inhibitors	0.065
Anti-Ulcer Agents	0.065
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.064
Antihypertensive Agents	0.064
Diuretics	0.062
Platelet Aggregation Inhibitors	0.062
Hypolipidemic Agents	0.061
Anti-Arrhythmia Agents	0.061
Fibrinolytic Agents	0.058
Cyclooxygenase Inhibitors	0.057
Anti-Inflammatory Agents, Non-Steroidal	0.057
Antipyretics	0.055
Anti-Inflammatory Agents	0.055
===== phenotype 27=================================================================
proportion of pts: 0.120983736612
lambda: 14398.6275401
----------------------------------------
Hypertensive disease	0.119
General symptoms	0.104
Symptoms involving respiratory system and other chest symptoms	0.097
Range name na	0.092
Disorders of lipoid metabolism	0.084
Symptoms involving head and neck	0.076
Nutritional deficiencies	0.072
Other diseases of intestines and peritoneum	0.068
Symptoms involving urinary system	0.063
Disorders of the eye and adnexa	0.061
Diseases of the ear and mastoid process	0.057
Dorsopathies	0.055
Anemias	0.053
----------------------------------------
Vitamins	0.075
Calcium Channel Blockers	0.072
Angiotensin-Converting Enzyme Inhibitors	0.071
Cardiotonic Agents	0.068
Vasodilator Agents	0.067
Bone Density Conservation Agents	0.066
Platelet Aggregation Inhibitors	0.065
Fibrinolytic Agents	0.064
Antihypertensive Agents	0.062
Antipyretics	0.061
Cyclooxygenase Inhibitors	0.059
Anti-Ulcer Agents	0.059
Anti-Inflammatory Agents, Non-Steroidal	0.058
Antioxidants	0.052
Anti-Allergic Agents	0.050
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.050
===== phenotype 13=================================================================
proportion of pts: 0.142403808013
lambda: 14356.2044318
----------------------------------------
Diabetes	0.231
Hypertensive disease	0.166
Disorders of lipoid metabolism	0.165
Ischemic heart disease	0.104
General symptoms	0.077
Range name na	0.077
Disorders of the eye and adnexa	0.075
Dorsopathies	0.053
Rheumatism, excluding the back	0.053
----------------------------------------
Hypoglycemic Agents	0.104
Anti-Arrhythmia Agents	0.074
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.074
Anticholesteremic Agents	0.071
Adrenergic beta-1 Receptor Antagonists	0.070
Sympatholytics	0.065
Angiotensin-Converting Enzyme Inhibitors	0.064
Platelet Aggregation Inhibitors	0.063
Antihypertensive Agents	0.062
Fibrinolytic Agents	0.062
Anti-Inflammatory Agents, Non-Steroidal	0.061
Cyclooxygenase Inhibitors	0.061
Antipyretics	0.057
Hypolipidemic Agents	0.057
Vasodilator Agents	0.055
===== phenotype 9=================================================================
proportion of pts: 0.121380404601
lambda: 13142.6951011
----------------------------------------
Diabetes	0.152
Hypertensive disease	0.103
Disorders of lipoid metabolism	0.098
Rheumatism, excluding the back	0.079
Disorders of the eye and adnexa	0.078
Organic sleep disorders	0.071
Symptoms involving skin and other integumentary tissue	0.067
Range name na	0.066
Diseases of the ear and mastoid process	0.065
Other diseases of the upper respiratory tract	0.059
Arthropathies and related disorders	0.057
Symptoms involving urinary system	0.053
Nutritional deficiencies	0.052
----------------------------------------
Hypoglycemic Agents	0.102
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.086
Anticholesteremic Agents	0.081
Platelet Aggregation Inhibitors	0.080
Anti-Inflammatory Agents, Non-Steroidal	0.080
Antipyretics	0.079
Cyclooxygenase Inhibitors	0.078
Fibrinolytic Agents	0.076
Hypolipidemic Agents	0.074
Antihypertensive Agents	0.074
Angiotensin-Converting Enzyme Inhibitors	0.067
Anti-Inflammatory Agents	0.063
Anti-Allergic Agents	0.060
===== phenotype 46=================================================================
proportion of pts: 0.126537088457
lambda: 12967.7578454
----------------------------------------
Disorders of thyroid gland	0.149
Hypertensive disease	0.123
Disorders of lipoid metabolism	0.116
Organic sleep disorders	0.104
Other symptoms involving abdomen and pelvis	0.072
Symptoms involving respiratory system and other chest symptoms	0.071
Dorsopathies	0.067
Diseases of esophagus, stomach, and duodenum	0.064
General symptoms	0.062
Range name na	0.059
Diabetes	0.057
Overweight, obesity and other hyperalimentation	0.056
----------------------------------------
Diuretics	0.081
Anti-Arrhythmia Agents	0.079
Anticholesteremic Agents	0.070
Antihypertensive Agents	0.069
Calcium Channel Blockers	0.069
Anti-Inflammatory Agents, Non-Steroidal	0.068
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.068
Cyclooxygenase Inhibitors	0.066
Sodium Chloride Symporter Inhibitors	0.066
Anti-Allergic Agents	0.062
Anti-Ulcer Agents	0.062
Platelet Aggregation Inhibitors	0.061
Antipyretics	0.061
Vasodilator Agents	0.058
Fibrinolytic Agents	0.058
===== phenotype 0=================================================================
proportion of pts: 0.126933756446
lambda: 11833.8350177
----------------------------------------
Other diseases of urinary system	0.124
Hypertensive disease	0.101
Disorders of lipoid metabolism	0.099
Symptoms involving urinary system	0.094
General symptoms	0.089
Diseases of male genital organs	0.073
Arthropathies and related disorders	0.070
Dorsopathies	0.064
Symptoms involving respiratory system and other chest symptoms	0.063
Range name na	0.060
Cerebrovascular disease	0.059
Hereditary and degenerative diseases of the central nervous system	0.054
Symptoms involving head and neck	0.050
----------------------------------------
Anticholesteremic Agents	0.095
Platelet Aggregation Inhibitors	0.093
Fibrinolytic Agents	0.091
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.091
Antipyretics	0.085
Cyclooxygenase Inhibitors	0.084
Antihypertensive Agents	0.084
Anti-Inflammatory Agents, Non-Steroidal	0.083
Hypolipidemic Agents	0.083
Vasodilator Agents	0.076
Angiotensin-Converting Enzyme Inhibitors	0.072
Anti-Arrhythmia Agents	0.063
===== phenotype 48=================================================================
proportion of pts: 0.109083696946
lambda: 11354.1764497
----------------------------------------
Diseases of esophagus, stomach, and duodenum	0.136
Hypertensive disease	0.100
Arthropathies and related disorders	0.092
Disorders of lipoid metabolism	0.085
Symptoms involving respiratory system and other chest symptoms	0.082
Rheumatism, excluding the back	0.079
General symptoms	0.078
Disorders of thyroid gland	0.067
Symptoms involving digestive system	0.063
Other symptoms involving abdomen and pelvis	0.059
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.054
Acute respiratory infections	0.053
Nonspecific findings on examination of blood	0.053
----------------------------------------
Proton Pump Inhibitors	0.102
Anti-Ulcer Agents	0.091
Vitamins	0.089
Anti-Inflammatory Agents, Non-Steroidal	0.082
Cyclooxygenase Inhibitors	0.081
Platelet Aggregation Inhibitors	0.079
Bone Density Conservation Agents	0.078
Fibrinolytic Agents	0.074
Antipyretics	0.072
Antihypertensive Agents	0.070
Vasodilator Agents	0.063
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.060
Anti-Inflammatory Agents	0.058
===== phenotype 34=================================================================
proportion of pts: 0.114240380801
lambda: 10956.1843624
----------------------------------------
Hypertensive disease	0.104
Range name na	0.099
Rheumatism, excluding the back	0.089
Diabetes	0.084
Other forms of heart disease	0.083
Disorders of lipoid metabolism	0.080
Arthropathies and related disorders	0.078
General symptoms	0.072
Disorders of the eye and adnexa	0.071
Diseases of veins and lymphatics, and other diseases of circulatory system	0.066
Symptoms involving skin and other integumentary tissue	0.060
Disorders of thyroid gland	0.058
Dorsopathies	0.056
----------------------------------------
Diuretics	0.134
Calcium Channel Blockers	0.122
Sodium Potassium Chloride Symporter Inhibitors	0.118
Vasodilator Agents	0.107
Anti-Arrhythmia Agents	0.105
Sympatholytics	0.100
Anticoagulants	0.089
Rodenticides	0.083
Antihypertensive Agents	0.074
Anticholesteremic Agents	0.069
===== phenotype 22=================================================================
proportion of pts: 0.116620388735
lambda: 10644.7870989
----------------------------------------
Other diseases of the upper respiratory tract	0.148
Hypertensive disease	0.136
Symptoms involving respiratory system and other chest symptoms	0.120
Acute respiratory infections	0.116
Disorders of lipoid metabolism	0.090
Chronic obstructive pulmonary disease and allied conditions	0.090
Disorders of the eye and adnexa	0.075
Diseases of esophagus, stomach, and duodenum	0.064
Symptoms involving skin and other integumentary tissue	0.054
Dorsopathies	0.054
Symptoms involving head and neck	0.052
----------------------------------------
Bronchodilator Agents	0.104
Anti-Inflammatory Agents	0.097
Dermatologic Agents	0.096
Anti-Allergic Agents	0.095
Histamine H1 Antagonists, Non-Sedating	0.094
Glucocorticoids	0.090
Anti-Bacterial Agents	0.087
Proton Pump Inhibitors	0.079
Anti-Ulcer Agents	0.078
Antihypertensive Agents	0.075
Adrenergic beta-2 Receptor Agonists	0.052
Lipoxygenase Inhibitors	0.052
===== phenotype 42=================================================================
proportion of pts: 0.109083696946
lambda: 10289.8203224
----------------------------------------
Hypertensive disease	0.122
General symptoms	0.098
Range name na	0.089
Disorders of lipoid metabolism	0.084
Symptoms involving respiratory system and other chest symptoms	0.083
Arthropathies and related disorders	0.080
Rheumatism, excluding the back	0.075
Symptoms involving head and neck	0.073
Dorsopathies	0.069
Disorders of the eye and adnexa	0.065
Symptoms involving digestive system	0.056
Acute respiratory infections	0.055
Other diseases of the upper respiratory tract	0.052
----------------------------------------
Anticonvulsants	0.134
Hypnotics and Sedatives	0.134
Anti-Anxiety Agents	0.129
Antiemetics	0.123
GABA Modulators	0.121
Serotonin Uptake Inhibitors	0.093
Histamine H1 Antagonists	0.091
Analgesics	0.090
Antidepressive Agents, Second-Generation	0.085
===== phenotype 20=================================================================
proportion of pts: 0.112257040857
lambda: 10143.6265497
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.139
Hypertensive disease	0.085
Malignant neoplasm of skin	0.084
Neoplasm of uncertain behavior of other sites & tissues	0.079
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.076
Symptoms involving skin and other integumentary tissue	0.075
Infections of skin and subcutaneous tissue	0.072
Rheumatism, excluding the back	0.072
Arthropathies and related disorders	0.071
Other forms of heart disease	0.066
Range name na	0.065
Dorsopathies	0.063
Other inflammatory conditions of skin and subcutaneous tissue	0.055
----------------------------------------
Platelet Aggregation Inhibitors	0.104
Fibrinolytic Agents	0.100
Antipyretics	0.099
Vitamins	0.094
Anti-Inflammatory Agents, Non-Steroidal	0.093
Cyclooxygenase Inhibitors	0.092
Antihypertensive Agents	0.092
Bone Density Conservation Agents	0.085
Anti-Arrhythmia Agents	0.081
Vasodilator Agents	0.080
Diuretics	0.079
===== phenotype 12=================================================================
proportion of pts: 0.101943673146
lambda: 10042.9241363
----------------------------------------
Other forms of heart disease	0.130
Range name na	0.108
Ischemic heart disease	0.099
Hypertensive disease	0.098
Disorders of lipoid metabolism	0.097
Symptoms involving respiratory system and other chest symptoms	0.081
Arthropathies and related disorders	0.076
Other symptoms involving abdomen and pelvis	0.070
Rheumatism, excluding the back	0.063
Organic sleep disorders	0.060
Dorsopathies	0.060
Acute respiratory infections	0.058
----------------------------------------
Anticoagulants	0.087
Rodenticides	0.079
Anti-Arrhythmia Agents	0.079
Sympatholytics	0.075
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.074
Histamine H1 Antagonists, Non-Sedating	0.073
Anticholesteremic Agents	0.073
Anti-Allergic Agents	0.072
Hypolipidemic Agents	0.071
Platelet Aggregation Inhibitors	0.067
Fibrinolytic Agents	0.066
Antipyretics	0.062
Cyclooxygenase Inhibitors	0.061
Anti-Inflammatory Agents, Non-Steroidal	0.061
===== phenotype 21=================================================================
proportion of pts: 0.104720349068
lambda: 9814.33701392
----------------------------------------
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.111
Arthropathies and related disorders	0.104
Rheumatism, excluding the back	0.092
Hypertensive disease	0.091
Range name na	0.079
Other diseases of urinary system	0.075
Dorsopathies	0.073
Symptoms involving urinary system	0.070
General symptoms	0.066
Disorders of the peripheral nervous system	0.066
Diseases of esophagus, stomach, and duodenum	0.063
Anemias	0.057
Fractures	0.052
----------------------------------------
Calcium Channel Blockers	0.121
Anti-Ulcer Agents	0.105
Anticonvulsants	0.104
Anti-Arrhythmia Agents	0.102
Anti-Anxiety Agents	0.101
Analgesics	0.101
Serotonin Uptake Inhibitors	0.088
Antipyretics	0.081
Antihypertensive Agents	0.067
Cyclooxygenase Inhibitors	0.066
Anti-Inflammatory Agents, Non-Steroidal	0.065
===== phenotype 17=================================================================
proportion of pts: 0.0987703292344
lambda: 8637.87212332
----------------------------------------
Hypertensive disease	0.125
Gout	0.124
Range name na	0.105
Disorders of lipoid metabolism	0.105
Ischemic heart disease	0.092
Other forms of heart disease	0.085
Arthropathies and related disorders	0.069
Dorsopathies	0.068
Diabetes	0.062
Diseases of male genital organs	0.058
Benign neoplasm of other parts of digestive system	0.054
Disorders of the eye and adnexa	0.053
----------------------------------------
Gout Suppressants	0.105
Adrenergic alpha-1 Receptor Antagonists	0.090
Enzyme Inhibitors	0.088
Antimetabolites	0.086
Antihypertensive Agents	0.074
Free Radical Scavengers	0.074
Anti-Inflammatory Agents, Non-Steroidal	0.072
Antipyretics	0.072
Cyclooxygenase Inhibitors	0.071
Vasodilator Agents	0.070
Platelet Aggregation Inhibitors	0.068
Fibrinolytic Agents	0.067
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.062
===== phenotype 11=================================================================
proportion of pts: 0.115430384768
lambda: 8191.96639526
----------------------------------------
Hypertensive disease	0.145
Range name na	0.143
Rheumatism, excluding the back	0.108
Arthropathies and related disorders	0.108
General symptoms	0.100
Disorders of lipoid metabolism	0.096
Symptoms involving respiratory system and other chest symptoms	0.084
Dorsopathies	0.082
Other forms of heart disease	0.073
Diabetes	0.062
----------------------------------------
Analgesics, Opioid	0.132
Narcotics	0.125
Immunosuppressive Agents	0.096
Anti-Infective Agents, Urinary	0.095
Antimalarials	0.094
Enzyme Inhibitors	0.087
Antifungal Agents	0.084
Antirheumatic Agents	0.080
Anti-Infective Agents, Local	0.077
Anti-Infective Agents	0.066
Gastrointestinal Agents	0.064
===== phenotype 45=================================================================
proportion of pts: 0.0975803252678
lambda: 8007.38485514
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.116
Hypertensive disease	0.101
Neoplasm of uncertain behavior of other sites & tissues	0.097
Disorders of lipoid metabolism	0.091
Diseases of esophagus, stomach, and duodenum	0.075
General symptoms	0.075
Range name na	0.071
Benign neoplasm of skin	0.069
Symptoms involving respiratory system and other chest symptoms	0.067
Disorders of thyroid gland	0.064
Other inflammatory conditions of skin and subcutaneous tissue	0.063
Rheumatism, excluding the back	0.060
Neurotic, personality, nonpsychotic disorders	0.051
----------------------------------------
Proton Pump Inhibitors	0.109
Anti-Ulcer Agents	0.104
Anti-Allergic Agents	0.096
Antihypertensive Agents	0.087
Histamine H1 Antagonists, Non-Sedating	0.085
Anti-Inflammatory Agents	0.085
Bronchodilator Agents	0.083
Anticholesteremic Agents	0.083
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.078
Anti-Inflammatory Agents, Non-Steroidal	0.067
Cyclooxygenase Inhibitors	0.062
Antipyretics	0.060
===== phenotype 39=================================================================
proportion of pts: 0.123760412535
lambda: 8000.08030548
----------------------------------------
Nutritional deficiencies	0.151
Hypertensive disease	0.149
Range name na	0.115
Disorders of lipoid metabolism	0.107
Arthropathies and related disorders	0.098
Disorders of the eye and adnexa	0.091
Anemias	0.079
General symptoms	0.077
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.069
Na	0.063
----------------------------------------
Vitamins	0.141
Bone Density Conservation Agents	0.134
Vitamin B Complex	0.126
Antioxidants	0.116
Antihypertensive Agents	0.094
Serotonin Uptake Inhibitors	0.089
Anti-Inflammatory Agents, Non-Steroidal	0.080
Cyclooxygenase Inhibitors	0.075
Antipyretics	0.075
Dermatologic Agents	0.070
===== phenotype 28=================================================================
proportion of pts: 0.0944069813566
lambda: 7573.64773738
----------------------------------------
Disorders of lipoid metabolism	0.124
Ischemic heart disease	0.118
Symptoms involving respiratory system and other chest symptoms	0.109
Hypertensive disease	0.108
Chronic obstructive pulmonary disease and allied conditions	0.095
Other diseases of skin and subcutaneous tissue	0.089
Cerebrovascular disease	0.084
General symptoms	0.075
Acute respiratory infections	0.068
Arthropathies and related disorders	0.067
Range name na	0.063
----------------------------------------
Anticholesteremic Agents	0.116
Hypolipidemic Agents	0.105
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.103
Vasodilator Agents	0.101
Platelet Aggregation Inhibitors	0.094
Fibrinolytic Agents	0.089
Explosive Agents	0.087
Cyclooxygenase Inhibitors	0.080
Anti-Inflammatory Agents, Non-Steroidal	0.080
Antipyretics	0.075
Antihypertensive Agents	0.071
===== phenotype 25=================================================================
proportion of pts: 0.115827052757
lambda: 7017.02414836
----------------------------------------
Dorsopathies	0.155
Arthropathies and related disorders	0.144
Hypertensive disease	0.130
Rheumatism, excluding the back	0.128
Range name na	0.112
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.094
Disorders of lipoid metabolism	0.091
General symptoms	0.080
Disorders of the peripheral nervous system	0.066
----------------------------------------
Anti-Inflammatory Agents	0.135
Calcium Channel Blockers	0.134
Glucocorticoids	0.132
Anti-Allergic Agents	0.122
Dermatologic Agents	0.111
Bronchodilator Agents	0.101
Antihypertensive Agents	0.094
Anti-Inflammatory Agents, Non-Steroidal	0.089
Cyclooxygenase Inhibitors	0.084
===== phenotype 24=================================================================
proportion of pts: 0.085680285601
lambda: 6936.43841699
----------------------------------------
Hypertensive disease	0.147
Range name na	0.124
Arthropathies and related disorders	0.106
Disorders of lipoid metabolism	0.103
Symptoms involving respiratory system and other chest symptoms	0.098
Rheumatism, excluding the back	0.080
General symptoms	0.080
Diabetes	0.073
Ischemic heart disease	0.073
Symptoms involving skin and other integumentary tissue	0.061
Other inflammatory conditions of skin and subcutaneous tissue	0.054
----------------------------------------
Adrenergic beta-1 Receptor Antagonists	0.116
Enzyme Inhibitors	0.113
Immunosuppressive Agents	0.105
Sympatholytics	0.103
Folic Acid Antagonists	0.100
Dermatologic Agents	0.095
Nucleic Acid Synthesis Inhibitors	0.094
Antirheumatic Agents	0.093
Antimetabolites, Antineoplastic	0.091
Abortifacient Agents, Nonsteroidal	0.090
===== phenotype 19=================================================================
proportion of pts: 0.0805236017453
lambda: 6822.7840568
----------------------------------------
Hypertensive disease	0.142
Disorders of lipoid metabolism	0.101
Range name na	0.083
Arthropathies and related disorders	0.082
Disorders of thyroid gland	0.080
Diabetes	0.075
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.075
Nutritional deficiencies	0.069
Rheumatism, excluding the back	0.068
Other diseases of the upper respiratory tract	0.064
Disorders of the eye and adnexa	0.058
Symptoms involving digestive system	0.052
Symptoms involving head and neck	0.051
----------------------------------------
Dermatologic Agents	0.117
Enzyme Inhibitors	0.107
Bronchodilator Agents	0.099
Immunosuppressive Agents	0.096
Anti-Allergic Agents	0.092
Antirheumatic Agents	0.090
Abortifacient Agents, Nonsteroidal	0.080
Anti-Inflammatory Agents	0.080
Folic Acid Antagonists	0.080
Nucleic Acid Synthesis Inhibitors	0.079
Antimetabolites, Antineoplastic	0.079
===== phenotype 32=================================================================
proportion of pts: 0.0944069813566
lambda: 6454.71400953
----------------------------------------
Sprains and strains of joints and adjacent muscles	0.101
Rheumatism, excluding the back	0.101
Hypertensive disease	0.099
Arthropathies and related disorders	0.086
Diseases of oral cavity, salivary glands, and jaws	0.086
Dorsopathies	0.081
Symptoms involving respiratory system and other chest symptoms	0.076
Other diseases of skin and subcutaneous tissue	0.068
Range name na	0.064
Disorders of lipoid metabolism	0.064
Other inflammatory conditions of skin and subcutaneous tissue	0.060
Disorders of the eye and adnexa	0.059
Symptoms involving head and neck	0.054
----------------------------------------
Anti-Arrhythmia Agents	0.115
Anesthetics, Local	0.101
Antihypertensive Agents	0.089
Anti-Inflammatory Agents	0.086
Vasodilator Agents	0.083
Anti-Inflammatory Agents, Non-Steroidal	0.080
Anti-Allergic Agents	0.078
Cyclooxygenase Inhibitors	0.077
Antipyretics	0.077
Bronchodilator Agents	0.075
Platelet Aggregation Inhibitors	0.071
Fibrinolytic Agents	0.069
===== phenotype 31=================================================================
proportion of pts: 0.101150337168
lambda: 6206.3740215
----------------------------------------
Diseases of arteries, arterioles, and capillaries	0.123
Symptoms involving cardiovascular system	0.098
Other diseases of urinary system	0.091
Malignant neoplasm of male and female genital organs	0.084
Diseases of male genital organs	0.083
Other symptoms involving abdomen and pelvis	0.072
Other diseases of intestines and peritoneum	0.071
Diseases of veins and lymphatics, and other diseases of circulatory system	0.069
Other and unspecified effects of external causes	0.069
Other forms of heart disease	0.063
Hypertensive disease	0.062
Disorders of lipoid metabolism	0.059
Other bacterial diseases	0.057
----------------------------------------
Anticholesteremic Agents	0.108
Antihypertensive Agents	0.107
Antipyretics	0.102
Platelet Aggregation Inhibitors	0.101
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.100
Cyclooxygenase Inhibitors	0.098
Fibrinolytic Agents	0.097
Vasodilator Agents	0.097
Anti-Inflammatory Agents, Non-Steroidal	0.095
Anti-Arrhythmia Agents	0.095
===== phenotype 8=================================================================
proportion of pts: 0.09678698929
lambda: 6177.71505624
----------------------------------------
Hypertensive disease	0.103
Symptoms involving respiratory system and other chest symptoms	0.098
Disorders of lipoid metabolism	0.095
Diseases of esophagus, stomach, and duodenum	0.093
Range name na	0.090
Ischemic heart disease	0.077
Diabetes	0.075
General symptoms	0.069
Hernia of abdominal cavity	0.065
Other symptoms involving abdomen and pelvis	0.063
Nutritional deficiencies	0.060
Dorsopathies	0.060
Diseases of veins and lymphatics, and other diseases of circulatory system	0.051
----------------------------------------
Proton Pump Inhibitors	0.209
Anti-Ulcer Agents	0.186
Hypnotics and Sedatives	0.165
Anti-Anxiety Agents	0.150
GABA Modulators	0.125
Antipyretics	0.084
Antihypertensive Agents	0.082
===== phenotype 43=================================================================
proportion of pts: 0.0963903213011
lambda: 5795.7673116
----------------------------------------
General symptoms	0.097
Acute respiratory infections	0.097
Disorders of the eye and adnexa	0.096
Range name na	0.093
Hypertensive disease	0.082
Symptoms involving respiratory system and other chest symptoms	0.077
Infections of skin and subcutaneous tissue	0.068
Other symptoms involving abdomen and pelvis	0.062
Symptoms concerning nutrition, metabolism, and development	0.057
Diseases of other endocrine glands	0.057
Other diseases of intestines and peritoneum	0.056
Disorders of lipoid metabolism	0.054
Coagulation or hemorrhagic diseases	0.052
Benign neoplasm of other parts of digestive system	0.051
----------------------------------------
Antihypertensive Agents	0.117
Anti-Inflammatory Agents, Non-Steroidal	0.106
Diuretics	0.104
Anti-Inflammatory Agents	0.104
Cyclooxygenase Inhibitors	0.103
Antipyretics	0.100
Vasodilator Agents	0.096
Dermatologic Agents	0.093
Platelet Aggregation Inhibitors	0.091
Fibrinolytic Agents	0.087
===== phenotype 40=================================================================
proportion of pts: 0.0674335581119
lambda: 5773.09931406
----------------------------------------
Miscellaneous diagnostic and therapeutic procedures	0.170
Operations on the cardiovascular system	0.129
Other diseases of respiratory system	0.098
Operations on the musculoskeletal system	0.071
Diseases of veins and lymphatics, and other diseases of circulatory system	0.070
Diseases of arteries, arterioles, and capillaries	0.068
Symptoms involving respiratory system and other chest symptoms	0.058
